MedPath
HSA Approval

NEODERM CREAM

SIN10451P

NEODERM CREAM

NEODERM CREAM

November 23, 1998

POLYMEDIC TRADING ENTERPRISE PTE LTD

POLYMEDIC TRADING ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPOLYMEDIC TRADING ENTERPRISE PTE LTD
Licence HolderPOLYMEDIC TRADING ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D07XC01

betamethasone

Manufacturer Information

POLYMEDIC TRADING ENTERPRISE PTE LTD

TAI GUK PHARM IND CO LTD

Active Ingredients

BETAMETHASONE DIPROPIONATE EQV BETAMETHASONE

0.5 mg/g

Betamethasone

CLOTRIMAZOLE

10 mg/g

Clotrimazole

GENTAMICIN SULPHATE EQV GENTAMICIN BASE

1 mg/g

Gentamicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.